Bladder News and Research

RSS

MT Services reports Actos drug cases, updates settlement news

MT Services LLC, a Lawsuit Settlement News Reporting Company which operates lawsuitsettlementnews.com, announced today a primary focus on assisting plaintiffs of the after effects of the pharmaceutical drug Actos.

23 Sep 2014

Storage symptoms more severe in men with comorbid diabetes

A study of men with lower urinary tract symptoms and benign prostatic hyperplasia suggests that the presence of comorbid diabetes is associated with more severe urological symptoms.

22 Sep 2014

OABSS reveals impact of symptoms on women’s quality of life

The Overactive Bladder Symptom Score questionnaire is valuable for assessing the impact of OAB symptoms on women’s health-related quality of life, shows a large survey of Japanese women.

22 Sep 2014

Common type of hospital-associated infections can be prevented with vaccine

The most common type of hospital-associated infection may be preventable with a vaccine, new research in mice suggests.

18 Sep 2014

Urinary nerve growth factor shows diagnostic value

Urinary nerve growth factor could be a useful biomarker for the diagnosis of overactive bladder and a predictive biomarker to help guide treatment, Chinese researchers believe.

17 Sep 2014

Sacral neuromodulation augments efficacy of antimuscarinics in OAB

The addition of sacral neuromodulation to antimuscarinic pharmacotherapy offers significant benefits over antimuscarinics alone in the treatment of women with idiopathic overactive bladder, study findings show.

17 Sep 2014

Collaborative study takes important step toward finding targeted treatments for bladder cancer

The story of cancer care seems so simple: find the mutated gene that causes cancer and turn it off or fix it. But rarely does a single gene cause cancer. More often, many genes are altered together to drive the disease. So the challenge becomes sorting out which altered genes are the most to blame in which cancers.

16 Sep 2014

BGI-VPC Joint Research Laboratory to apply genome research to develop new cancer therapies

BGI, the world’s largest genomics organization, based in China, and The Vancouver Prostate Centre, a global leader in translational research in cancer, today announced the establishment of the BGI-VPC Joint Research Laboratory, a sequencing and translational research facility, to jointly discover and advance basic and translational programs in oncology, including personalized oncology.

15 Sep 2014

Loyola announces opening of new acupuncture clinic for patients with pelvic health disorders

Loyola University Health System will open an acupuncture clinic for men and women with pelvic health disorders this fall. The clinic will use acupuncture to treat patients with common conditions such as pelvic pain, nausea from pelvic surgery, interstitial cystitis, painful bladder syndrome, postoperative pain, prostatitis and overactive bladder.

11 Sep 2014

Experts share tips on prevention of prostate cancer

Prostate cancer is the second leading cause of cancer death in American men. One in seven men will be diagnosed with prostate cancer and 233,000 new cases are diagnosed annually.

9 Sep 2014

Keytruda drug gets FDA approval for treatment of advanced melanoma

The U.S. Food and Drug Administration today approved a new immunotherapy drug to treat advanced melanoma, signaling a paradigm shift in the way the deadly skin cancer is treated.

5 Sep 2014

Ascend Biopharmaceuticals provides update on clinical trial program for lead immunotherapy products

Ascend Biopharmaceuticals, a Melbourne-based immunotherapy company, has released an update on the clinical trial pipeline for its lead immunotherapy products treating basal cell carcinoma (BCC) and breast cancer.

4 Sep 2014

Transplantation of B10 cells helps inhibit development of bladder fibrosis post SCI

A team of researchers from Korea and Canada have found that transplantation of B10 cells (a stable immortalized human bone marrow derived -mesenchymal stem cell line; B10 hMSC) directly into the bladder wall of mice modeled with spinal cord injury (SCI) helped inhibit the development of bladder fibrosis and improved bladder function by promoting the growth of smooth muscle cells in the bladder.

4 Sep 2014

Pacific Edge signs agreement with SCPMG to evaluate Cxbladder User Program

Pacific Edge Ltd, a cancer diagnostics company, has signed an agreement with Southern California Permanente Medical Group (SCPMG) to research its User Program to evaluate its bladder cancer technology Cxbladder within the clinical settings of Kaiser Permanente's health care network.

3 Sep 2014

No added benefit determined from Mirabegron for mortality, morbidity and quality of life

Mirabegron (trade name: Betmiga) has been approved since December 2012 for the treatment of adults with overactive bladder.

3 Sep 2014

Do small military hospitals meet the grade?

The New York Times takes a critical look at small military hospitals where the limited number of patients may compromise doctors' ability to treat serious problems. Other stories look at a surge in surgery prices and at programs to standardize children's surgical care.

3 Sep 2014

Yoga program for MS patients improves physical and mental well-being

Paula Meltzer was only 38 when out of nowhere everything she looked at was blurry. For the single mother, who had a lucrative career as a gemologist and spent hours examining valuable pieces of jewelry, it seemed as if - in a split second - her life changed.

3 Sep 2014

Concordia's subsidiary signs collaboration deal with Orphan Canada for PHOTOFRIN

Concordia Healthcare Corp., a diverse healthcare company focused on legacy pharmaceutical products, orphan drugs, and medical devices for the diabetic population, today announced that its subsidiary, Pinnacle Biologics, Inc., a biopharmaceutical research and development company specializing in rare diseases, has signed a collaboration agreement for PHOTOFRIN® with Orphan Canada, a Toronto-based specialty pharmaceutical company that in‐licenses therapies for rare disorders and specialty medicines within Canada.

2 Sep 2014

Transobturator tape improves OAB symptoms including nocturia

The use of transobturator tape offers significant relief from symptoms of overactive bladder in patients with mixed urinary incontinence, study findings indicate.

1 Sep 2014

Invisible blood in urine: An early warning sign of bladder cancer

New research which finds that invisible blood in urine may be an early warning sign of bladder cancer is likely to shape guidelines for clinicians.

1 Sep 2014

Bladder News and Research

MT Services reports Actos drug cases, updates settlement news

Storage symptoms more severe in men with comorbid diabetes

OABSS reveals impact of symptoms on women’s quality of life

Common type of hospital-associated infections can be prevented with vaccine

Urinary nerve growth factor shows diagnostic value

Sacral neuromodulation augments efficacy of antimuscarinics in OAB

Collaborative study takes important step toward finding targeted treatments for bladder cancer

BGI-VPC Joint Research Laboratory to apply genome research to develop new cancer therapies

Loyola announces opening of new acupuncture clinic for patients with pelvic health disorders

Experts share tips on prevention of prostate cancer

Keytruda drug gets FDA approval for treatment of advanced melanoma

Ascend Biopharmaceuticals provides update on clinical trial program for lead immunotherapy products

Transplantation of B10 cells helps inhibit development of bladder fibrosis post SCI

Pacific Edge signs agreement with SCPMG to evaluate Cxbladder User Program

No added benefit determined from Mirabegron for mortality, morbidity and quality of life

Do small military hospitals meet the grade?

Yoga program for MS patients improves physical and mental well-being

Concordia's subsidiary signs collaboration deal with Orphan Canada for PHOTOFRIN

Transobturator tape improves OAB symptoms including nocturia

Invisible blood in urine: An early warning sign of bladder cancer

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News